Cardiovascular Research

The association of nadir CD4-T cell count and endothelial dysfunction in a healthy HIV cohort without major cardiovascular risk

Authors: Emad Mogadam|||Kevin King|||Kimberly Shriner|||Karen Chu|||Anders Sondergaard|||Kristal Young|||Morteza Naghavi|||Robert A Kloner

Affiliations: + Expand

Abstract

HIV-infected population may have increased risk of cardiovascular disease. The prevalence of traditional cardiovascular disease risk factors such as hypertension, diabetes and dyslipidemia in HIV-infected individuals has made it difficult to assess the direct effects of HIV and immune factors on endothelial dysfunction and associated increased risk of atherosclerosis. The purpose of this study was to investigate indicators of endothelial dysfunction in an HIV cohort without hypertension and diabetes.

---

Reference List

Hsue PY. Mechanisms of cardiovascular disease in the setting of HIV infection. Can J Cardiol 2019; 35(3): 238–248.|||Friis-Moller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. AIDS 2003; 17(8): 1179–1193.|||Holmberg SD, Moorman AC, Williamson JM, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002; 360(9347): 1747–1748.|||Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004; 109(13): 1603–1608.|||Dau B, Holodniy M. The relationship between HIV infection and cardiovascular disease. Curr Cardiol Rev 2008; 4(3): 203–218.|||Ho JE, Scherzer R, Hecht FM, et al. The association of CD4+ T-cell count on cardiovascular risk in treated HIV disease. AIDS 2012; 26: PMC3881548.|||Dysangco A, Liu Z, Stein JH, et al. HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress. PLoS ONE 2017; 12(8): e0183511.|||Ho JE, Scherzer R, Hecht FM, et al. The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS 2012; 26(9): 1115–1120.|||Lang S, Boccara F, Mary-Krause M, et al. Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries. Arch Cardiovasc Dis 2015; 108(3): 206–215.|||Kistler A, Mariauzouls C, von Berlepsch K. Fingertip temperature as an indicator for sympathetic responses. Int J Psychophysiol 1998; 29(1): 35–41.|||Naghavi M, Yen AA, Lin AWH, et al. New indices of endothelial function measured by digital thermal monitoring of vascular reactivity: data from 6084 patients registry. Int J Vasc Med 2016; 2016: 1348028.|||Ahmadi N, Usman N, Shim J, et al. Vascular dysfunction measured by fingertip thermal monitoring is associated with the extent of myocardial perfusion defect. J Nucl Cardiol 2009; 16(3): 431–439.|||Ahmadi N, Nabavi V, Nuguri V, et al. Low fingertip temperature rebound measured by digital thermal monitoring strongly correlates with the presence and extent of coronary artery disease diagnosed by 64-slice multi-detector computed tomography. Int J Cardiovasc Imaging 2009; 25(7): 725–738.|||Gul KM, Ahmadi N, Wang Z, et al. Digital thermal monitoring of vascular function: a novel tool to improve cardiovascular risk assessment. Vasc Med 2009; 14(2): 143–148.|||Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: III27–III32.|||Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126.|||Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–1695.|||Matsuzawa Y, Sugiyama S, Sumida H, et al. Peripheral endothelial function and cardiovascular events in high-risk patients. J Am Heart Assoc 2013; 2(6): e000426.|||Lichtenstein KA, Armon C, Buchacz K, et al. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis 2010; 51(4): 435–447.|||Blum A, Hadas V, Burke M, et al. Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction. Clin Cardiol 2005; 28(3): 149–153.|||Post WS, Budoff M, Kingsley L, et al. Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med 2014; 160(7): 458–467.|||Kaplan RC, Kingsley LA, Gange SJ, et al. Low CD4+ T cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008; 22(13): 1615–1624.|||Hunt PW, Martin JN, Sinclair E, et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003; 187(10): 1534–1543.|||Funderburg NT, Jiang Y, Debanne SM, et al. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy. Clin Infect Dis 2013; 58: 588–595.|||Saif MW, Bona R, Greenberg B. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS 2001; 15(6): 311–320.|||El-Sadr WM, Mullin CM, Carr A, et al. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort. HIV Med 2005; 6(2): 114–121.|||Floris-Moore M, Howard AA, Lo Y, et al. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women. HIV Med 2006; 7(7): 421–430.|||Ahmadi N, Hajsadeghi F, Gul K, et al. Relations between digital thermal monitoring of vascular function, the Framingham risk score, and coronary artery calcium score. J Cardiovasc Comput Tomogr 2008; 2(6): 382–388.|||Akhtar MW, Kleis SJ, Metcalfe RW, et al. Sensitivity of digital thermal monitoring parameters to reactive hyperemia. J Biomech Eng 2010; 132(5): 051005.